Company profile ABUS

Arbutus Biopharma Corp
arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will res...ult in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease. in addition to our hbv assets, we are developing a pipeline of programs that leverage our expertise in rna interference (rnai) therapeutics and our lipid nanoparticle (lnp) technology. Show More
Quarter analysis & expected interestLast update: February 08 2024 12:46:43.

After 39 days of this quarter the interest is at 6.0. Based on that we can calculate that during remaining 52 days it will total up to 14.0.
Arbutus Biopharma expected interest is significantly lower compared to same quarter last year (-44.0%) but higher than previous quarter (+600.0%).

YearQ1Q2Q3Q4
201917
22
29.4% QoQ
16
-27.3% QoQ
13
-18.8% QoQ
2020 27
58.8% YoY 107.7% QoQ
45
104.5% YoY 66.7% QoQ
194
1112.5% YoY 331.1% QoQ
51
292.3% YoY -73.7% QoQ
2021 40
48.1% YoY -21.6% QoQ
15
-66.7% YoY -62.5% QoQ
26
-86.6% YoY 73.3% QoQ
65
27.5% YoY 150.0% QoQ
2022 39
-2.5% YoY -40.0% QoQ
23
53.3% YoY -41.0% QoQ
14
-46.2% YoY -39.1% QoQ
28
-56.9% YoY 100.0% QoQ
2023 25
-35.9% YoY -10.7% QoQ
22
-4.3% YoY -12.0% QoQ
19
35.7% YoY -13.6% QoQ
2
-92.9% YoY -89.5% QoQ
2024 6
-76.0% YoY 200.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Arbutus Biopharma search interestLast update: February 08 2024 12:46:42.
Correlation coefficient between keyword and revenue is -0.16
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:46:44.

The average 5 years interest of Arbutus Biopharma was 2.72 per week.
The last year interest of Arbutus Biopharma compared to the last 5 years has changed by -58.82%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -24.32%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Arbutus Biopharma Hepatitis to provide analysis

Correlation between past revenue and Arbutus Biopharma Hepatitis search interest

There is not enough data for Arbutus Biopharma Hepatitis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Arbutus Biopharma Hepatitis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Arbutus Biopharma AB-729 to provide analysis

Correlation between past revenue and Arbutus Biopharma AB-729 search interest

There is not enough data for Arbutus Biopharma AB-729 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Arbutus Biopharma AB-729 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Arbutus Biopharma SARS-CoV-2 to provide analysis

Correlation between past revenue and Arbutus Biopharma SARS-CoV-2 search interest

There is not enough data for Arbutus Biopharma SARS-CoV-2 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Arbutus Biopharma SARS-CoV-2 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Arbutus Biopharma coronavirus to provide analysis

Correlation between past revenue and Arbutus Biopharma coronavirus search interest

There is not enough data for Arbutus Biopharma coronavirus to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Arbutus Biopharma coronavirus to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Arbutus Biopharma careers to provide analysis

Correlation between past revenue and Arbutus Biopharma careers search interest

There is not enough data for Arbutus Biopharma careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Arbutus Biopharma careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:42:12.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Arbutus Biopharma news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201911
74
572.7% QoQ
36
-51.4% QoQ
15
-58.3% QoQ
2020 46
318.2% YoY 206.7% QoQ
58
-21.6% YoY 26.1% QoQ
173
380.6% YoY 198.3% QoQ
55
266.7% YoY -68.2% QoQ
2021 42
-8.7% YoY -23.6% QoQ
25
-56.9% YoY -40.5% QoQ
43
-75.1% YoY 72.0% QoQ
20
-63.6% YoY -53.5% QoQ
2022 58
38.1% YoY 190.0% QoQ
24
-4.0% YoY -58.6% QoQ
13
-69.8% YoY -45.8% QoQ
30
50.0% YoY 130.8% QoQ
2023 31
-46.6% YoY 3.3% QoQ
16
-33.3% YoY -48.4% QoQ
20
53.8% YoY 25.0% QoQ
21
-30.0% YoY 5.0% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Arbutus Biopharma news search interestLast update: February 08 2024 12:46:48.
Correlation coefficient between keyword and revenue is -0.19
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:42:14.

The average 5 years interest of Arbutus Biopharma news was 3.11 per week.
The last year interest of Arbutus Biopharma news compared to the last 5 years has changed by -49.2%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -42.12%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 12:46:55.

After 39 days of this quarter the interest is at 9.0. Based on that we can calculate that during remaining 52 days it will total up to 21.0.
Arbutus Biopharma -stock -company expected interest is significantly higher compared to previous quarter (+75.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201915
25
66.7% QoQ
33
32.0% QoQ
22
-33.3% QoQ
2020 54
260.0% YoY 145.5% QoQ
15
-40.0% YoY -72.2% QoQ
196
493.9% YoY 1206.7% QoQ
31
40.9% YoY -84.2% QoQ
2021 26
-51.9% YoY -16.1% QoQ
28
86.7% YoY 7.7% QoQ
22
-88.8% YoY -21.4% QoQ
44
41.9% YoY 100.0% QoQ
2022 56
115.4% YoY 27.3% QoQ
41
46.4% YoY -26.8% QoQ
21
-4.5% YoY -48.8% QoQ
20
-54.5% YoY -4.8% QoQ
2023 23
-58.9% YoY 15.0% QoQ
27
-34.1% YoY 17.4% QoQ
18
-14.3% YoY -33.3% QoQ
12
-40.0% YoY -33.3% QoQ
2024 9
-60.9% YoY -25.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Arbutus Biopharma -stock -company search interestLast update: February 08 2024 12:46:54.
Correlation coefficient between keyword and revenue is -0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:46:56.

The average 5 years interest of Arbutus Biopharma -stock -company was 2.83 per week.
The last year interest of Arbutus Biopharma -stock -company compared to the last 5 years has changed by -43.46%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -20.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ABUS
Earnings date: 2024-02-29 After close
Company name: Arbutus Biopharma Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T11:30:00Z

GlobeNewswire
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

2026-05-01T10:32:33.255Z

Reuters
Moderna tops revenue estimates on stronger international COVID vaccine sales

2026-04-15T11:30:00Z

GlobeNewswire
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

2026-03-23T11:30:00Z

GlobeNewswire
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

2026-03-04T13:14:54Z

Analyst Upgrades
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

2026-03-03T21:15:00Z

GlobeNewswire
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna

2026-03-03T21:15:00Z

GlobeNewswire
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

2025-11-14T20:56:45Z

Analyst Upgrades
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

2025-11-13T12:30:00Z

GlobeNewswire
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update

2025-10-07T08:01:34-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - Arbutus Biopharma Corp (0001447028) (Filer)

2025-10-07T12:00:00Z

GlobeNewswire
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver MeetingĀ® 2025

2025-09-10T09:00:46-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - Arbutus Biopharma Corp (0001447028) (Filer)

2025-08-11T11:22:09Z

Analyst Upgrades
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

2025-08-06T16:08:29-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Arbutus Biopharma Corp (0001447028) (Issuer)

2025-08-06T16:06:24-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Arbutus Biopharma Corp (0001447028) (Issuer)